News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Bioabsorbable Therapeutics, Inc. Raises Series B Investment Round for Novel Biodegradable Stent Technology



5/10/2007 3:06:31 PM

MENLO PARK, Calif.--(BUSINESS WIRE)--Bioabsorbable Therapeutics Inc. announced the close of a Series B round of US$9MM today. CEO Patrick Rivelli said, “We are delighted with the investment round, led by Finistere Ventures LLC and ITX International Equity Corp. This investment will help us begin human clinical trials and move closer to regulatory approval and commercialization.”

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES